|
Volumn 94, Issue 6, 2002, Pages 406-407
|
Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
CYTOKINE;
G PROTEIN COUPLED RECEPTOR;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
N BENZYL N METHYLNITROSAMINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN;
PROSTAGLANDIN E2;
SULINDAC;
BARRETT ESOPHAGUS;
CANCER CELL CULTURE;
CANCER GROWTH;
CANCER MORTALITY;
CANCER RISK;
CARCINOGENESIS;
CELL PROLIFERATION;
COLUMNAR EPITHELIUM;
CONTROLLED STUDY;
DRUG ANTAGONISM;
DRUG MECHANISM;
EDITORIAL;
ENZYME ACTIVITY;
ENZYME INACTIVATION;
ESOPHAGUS CARCINOMA;
GASTROESOPHAGEAL REFLUX;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IN VITRO STUDY;
MALIGNANT TRANSFORMATION;
MORBIDITY;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
SQUAMOUS CELL METAPLASIA;
|
EID: 0037139523
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/94.6.406 Document Type: Editorial |
Times cited : (27)
|
References (14)
|